JP Morgan Chase’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $62.1M | Buy |
|
|||||
|
2025
Q2 | $50.9M | Sell |
|
|||||
|
2025
Q1 | $44.7M | Buy |
|
|||||
|
2024
Q4 | $35.6M | Buy |
|
|||||
|
2024
Q3 | $36.5M | Sell |
|
|||||
|
2024
Q2 | $204M | Sell |
|
|||||
|
2024
Q1 | $243M | Sell |
|
|||||
|
2023
Q4 | $244M | Sell |
|
|||||
|
2023
Q3 | $241M | Buy |
|
|||||
|
2023
Q2 | $269M | Buy |
|
|||||
|
2023
Q1 | $312M | Buy |
|
|||||
|
2022
Q4 | $333M | Buy |
|
|||||
|
2022
Q3 | $335M | Buy |
|
|||||
|
2022
Q2 | $322M | Buy |
|
|||||
|
2022
Q1 | $217M | Buy |
|
|||||
|
2021
Q4 | $216M | Buy |
|
|||||
|
2021
Q3 | $192M | Sell |
|
|||||
|
2021
Q2 | $300M | Buy |
|
|||||
|
2021
Q1 | $253M | Sell |
|
|||||
|
2020
Q4 | $304M | Buy |
|
|||||
|
2020
Q3 | $158M | Buy |
|
|||||
|
2020
Q2 | $181M | Buy |
|